Description
Ceritinib, marketed under the brand name Spexib, It is an prescription medication that has been approved to ceritinib (ZYKADIA) on April 29, 2014 for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.
What is Spexib (Ceritinib) ?
Ceritinib is a targeted therapy. It is an oral tyrosine kinase inhibitor. is used to treat non-small cell lung cancer caused by a defect in a certain gene. Ceritinib is used when the cancer has spread to other parts of the body. Ceritinib is usually given after other cancer medicines have been tried without success.
Ceritinib is an anaplastic lymphoma kinase (ALK)-positive inhibitor primarily used for the treatment of metastatic NSCLC. Previously, it was only indicated for patients who had developed resistant to crizotinib, another ALK-positive inhibitor, but has since had its usage expanded to serve as a primary option for metastatic NSCLC.
How to order approved “Spexib (Ceritinib) for ” Medicine?
Spexib (Ceritinib) Capsule is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Spexib and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
